Predicted protein targets (top 6)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CDK4 | P11802 | 1/20 | 0.33 |
| ▸ | CCND1 | P24385 | 1/20 | 0.33 |
| ▸ | HTR2A | P28223 | 1/20 | 0.31 |
| ▸ | HTR2C | P28335 | 1/20 | 0.31 |
| ▸ | CYP19A1 | P11511 | 3/20 | 0.30 |
| ▸ | PTGER3 | P43115 | 1/20 | 0.30 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20101427 | 0.75 | CDK4 (0.33) | CDK4CCND1CYP19A1 | |
| SCHEMBL25883901 | 0.75 | HTR2A (0.31) | HTR2AHTR2CCYP19A1 | |
| SCHEMBL25883908 | 0.68 | PTGER3 (0.34) | HTR2AHTR2CCYP19A1PTGER3 | |
| SCHEMBL25883897 | 0.68 | PTGER3 (0.34) | HTR2AHTR2CCYP19A1PTGER3 | |
| SCHEMBL20101432 | 0.65 | CDK4 (0.36) | CDK4CCND1HTR2AHTR2CCYP19A1 | |
| SCHEMBL25798844 | 0.62 | HTR2A (0.63) | CDK4CCND1HTR2AHTR2C | |
| SCHEMBL25243568 | 0.61 | TUBB4A (0.40) | CDK4CCND1HTR2AHTR2C | |
| SCHEMBL20101430 | 0.61 | HTR2A (0.43) | CDK4CCND1HTR2AHTR2C | |
| SCHEMBL2540725 | 0.60 | CYP19A1 (0.40) | HTR2AHTR2CCYP19A1 | |
| SCHEMBL25081097 | 0.60 | CYP19A1 (0.49) | HTR2AHTR2CCYP19A1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20180123051-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | DUK SAN NEOLUX CO., LTD. (KR) | 2018-05-03 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20180123051-A1 | COMPOUND FOR ORGANIC ELECTRIC ELEMENT, ORGANIC ELECTRIC ELEMENT USING THE SAME, AND ELECTRONIC DEVICE THEREOF | PIEZO1, ORAI2, OR10J3 | CDK4 2660/4885CCND1 2712/4885HTR2A 4848/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.